
KINSHASA, Congo (AP) — Congo on Monday announced the end of an Ebola outbreak that killed 43 people in one of the country's southern provinces, with authorities saying no new confirmed cases had been reported in the past 45 days.
Health Minister Roger Kamba said the 43 deaths were among 53 confirmed cases in the outbreak, which was first announced in September in the Kasai province town of Bulape. He said more than 27,000 people were vaccinated, including 4,000 front-line workers he credited with helping to stem the outbreak.
“Indeed, no new confirmed cases have been recorded for 45 consecutive days," Kamba said in the capital, Kinshasa.
The outbreak in Bulape, which spread to at least four neighboring towns, was the country's 16th since the disease first emerged in the Congo in 1976, and the 7th in Kasai province. The World Health Organization initially faced significant challenges in delivering the vaccine with limited access and scarce funds.
An Ebola outbreak from 2018 to 2020 in eastern Congo killed more than 1,000 people.
The latest outbreak added a fresh layer of worry for the Central African country, which has been battling the M23 rebel group, which launched a rapid assault in January in the eastern region of the country and has since occupied key cities.
latest_posts
- 1
Visual communication Programming for Fledglings - 2
German Cabinet advances bill to cut greenhouse emissions from fuels - 3
AI is providing emotional support for employees – but is it a valuable tool or privacy threat? - 4
Genome study reveals milestone in history of cat domestication - 5
Private sector revives the climate disaster database Trump tried to squash
Bold Colors, Playful Shapes, Handmade Textures: This Mexico City Home Is 100% Joyful!
Guaranteeing Quality Medical care with Federal medical care Benefit Plans.
The largest sun of 2026 rises today as Earth draws closest to our parent star
This widow influencer is using jokes to cope after her husband's death. It's OK if people don't get it.
Vote in favor of Your Number one Cake Type
Vote In favor of Your Favored Keeping an eye on
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials
Island Travel Guide: Must-Visit Objections for 2024
Apartment Turned Into Nightmare 'Ice Castle' After Tenant Shut Off Heat Causing Pipes to Burst: VIDEO












